References
- Resiere D, Mégarbane B, Valentino R, et al. Bothrops lanceolatus bites: guidelines for severity assessment and emergent management. Toxins (Basel). 2010;2:163–173.
- Thomas L, Chausson N, Uzan J, et al. Thrombotic stroke following snake bites by the “Fer-de-Lance” Bothrops lanceolatus in Martinique despite antivenom treatment: a report of three recent cases. Toxicon. 2006;48:23–28.
- Thomas L, Tyburn B, Ketterlé J, et al. Prognostic significance of clinical grading of patients envenomed by Bothrops lanceolatus in Martinique. Members of the Research Group on Snake Bite in Martinique. Trans R Soc Trop Med Hyg. 1998;92:542–545.
- Olive C, Théodose R, Thomas L, et al. [Etude bactériologique de la cavité buccale de Bothrops lanceolatus et adaptation de I’antibiothérapie après morsure de serpent en Martinique] (abstract). Rev Med Intern. 2000;21:599S.
- Ribeiro LA, Jorge MT, Lebrão ML. Prognostic factors for local necrosis in Bothrops jararaca (Brazilian pit viper) bites. Trans R Soc Trop Med Hyg. 2001;95:630–634.
- Bucher B, Canonge D, Thomas L, et al. Clinical indicators of envenoming and serum levels of venom antigens in patients bitten by Bothrops lanceolatus in Martinique. Research Group on Snake Bites in Martinique. Trans R Soc Trop Med Hyg. 1997;91:186–190.
- Thomas L, Tyburn B, Lang J, et al. Early infusion of a purified monospecific F(ab')2 antivenom serum for Bothrops lanceolatus bites in Martinique. Lancet. 1996;347:406.
- Thomas L, Tyburn B, Bucher B, et al. Prevention of thromboses in human patients with Bothrops lanceolatus envenoming in Martinique: failure of anticoagulants and efficacy of a monospecific antivenom. Am J Trop Med Hyg. 1995;52:419–426.